Marvell Technology Shares Climb on AI Chip Demand Optimism
China Coal Mine Incident Highlights Challenges to Energy Security Strategy Under Xi Jinping
SpaceX and OpenAI Potential IPOs Could Eclipse Berkshire Hathaways Market Cap on Debut
SP 500 Edges Higher Led by Healthcare and Tech Communication Services Lags
Googles Homepage Redesign A Small Visual Change With Big Strategic Implications
Former BP Chairman Hits Back at Anonymous Critics Defends Tenure Amid Allegations
SuperCom SPCB Q4 2025 Earnings Massive EPS Beat Surprises Market
MarineMax Inc HZO Q1 2026 Earnings EPS Falls Short of Expectations Amid Challenging Environment
SGML Q1 2026 Earnings EPS Surges Past Estimates Shares Rise 282
Oxford Industries OXM Q1 2026 Earnings Significant EPS Miss but Shares Rally
COLB Q1 2026 Earnings EPS Surpasses Expectations with 30 Beat
CLLS Q1 2026 Earnings NarrowerThanExpected Loss as GeneEditing Pipeline Advances
Charlton Aria Acquisition Rights CHARR Plunge 3289 to 008 as Selling Pressure Intensifies
Kezar Life Sciences KZR Stays Flat Key Levels and Technical Outlook
New Providence Acquisition Corp III Warrants NPACW Edges Higher as Warrants Test Key Resistance
Galata Acquisition Corp II Warrants Hold Steady at 030 as Key Levels Remain Defined
Inventiva IVA Slips 27 as Shares Test Key Support Levels
Gaza Flotilla Detainee Allegations Could Impact Israels International Relations and Economic Stability
CBUS Q1 2026 Earnings Narrowing Losses Surpass Expectations as Operational Progress Continues
Crescent Biopharma CBIO Surges 459 as Biotech Sector Gains Momentum
Voyager Acquisition Corp VACH Faces Steep Decline Testing Support Levels After 654 Drop
OFS Credit Company Inc OCCI Edges Higher Navigating Support and Resistance Levels
Silicon Valley Acquisition Corp SVAQ Holds Steady at 995 Consolidation in the SPAC Sector
PharmaCyte Biotech PMCB Edges Higher SupportHolding Action at 081
Seres Therapeutics MCRB Declines 593 as Selling Pressure Intensifies
Gorilla Technology Group Inc GRRR Capitalizes on Recent Momentum Approaches Key Resistance
Drugs Made In America Acquisition Corp DMAA Holds Steady at 1060 SPAC Stabilization in Focus